New study confirms bioengineered RSV protein vaccine evokes protective immune response

Researchers marked a major milestone in the effort to create an effective vaccine for respiratory syncytial virus (RSV), which can cause severe respiratory disease in children and the elderly.


Click here for original story, New study confirms bioengineered RSV protein vaccine evokes protective immune response


Source: ScienceDaily